Treatment of overactive bladder can be more complex in the context of benign prostatic hyperplasia, but a new trial met ...

Very interestingly, we also found that patients with end-stage heart failure have upregulated gene and protein levels of ...

A drug used for high blood pressure, known as rilmenidine, may also be effective in slowing the aging process.

National Institutes of Health researchers and collaborators have discovered over 100 new regions of the human genome, also known as genomic loci, that appear to influence a person’s blood pressure.

In February 2024, Ocuphire appointed Nirav Jhaveri, C.F.A, M.B.A., as Chief Financial Officer and Ashwath (Ash) Jayagopal, Ph.D., M.B.A., as Chief Scientific and Development Officer.

a selective alpha-2 adrenergic receptor agonist. BioXcel Therapeutics believes that BXCL501 potentially targets an important mediator of agitation, and the Company has observed anti-agitation results ...

Researchers investigated whether higher endogenous testosterone levels increase atrial fibrillation (AF) risk among healthy ...

For instance, in the case of SSRI-induced night sweats, some people have seen improvement by adding medications called alpha-adrenergic blockers, research shows. Waking up drenched every once in a ...

Taken only once a day, TRELEGY contains an anti-inflammatory ICS (inhaled corticosteroid) that reduces inflammation and swelling in the lungs, a LABA (long-acting beta 2-adrenergic agonist) ...

adrenergic receptor blocking agent that slows the sinus rate and decreases AV nodal conduction. The β-blocking activity of metoprolol has been shown by reduction in heart rate and cardiac output ...

Hypertension: By combining the therapeutic benefits of calcium channel blockers, angiotensin II receptor antagonists, and ...

Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of retinal and refractive eye disorders, today ...